These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1665793

  • 1. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y, Ashby CR, Schwartz JE, Wang RY.
    Eur J Pharmacol; 1991 Dec 17; 209(3):143-50. PubMed ID: 1665793
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons.
    Minabe Y, Ashby CR, Wang RY.
    Eur Neuropsychopharmacol; 1992 Jun 17; 2(2):127-33. PubMed ID: 1321681
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR, Pan H, Minabe Y, Toor A, Fishkin L, Wang RY.
    Synapse; 1995 Aug 17; 20(4):351-61. PubMed ID: 7482294
    [Abstract] [Full Text] [Related]

  • 5. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR.
    Synapse; 1996 Jan 17; 22(1):35-45. PubMed ID: 8822476
    [Abstract] [Full Text] [Related]

  • 6. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP, Minabe Y, Middlemiss DN, Shirayama Y, Hashimoto K, Ashby CR.
    Synapse; 2002 Dec 01; 46(3):129-39. PubMed ID: 12325040
    [Abstract] [Full Text] [Related]

  • 7. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF, Waszczak BL.
    Brain Res; 1990 Nov 26; 534(1-2):273-82. PubMed ID: 1981482
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
    Hand TH, Hu XT, Wang RY.
    Brain Res; 1987 Jul 14; 415(2):257-69. PubMed ID: 3607497
    [Abstract] [Full Text] [Related]

  • 9. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR, Jiang LH, Wang RY.
    Eur J Pharmacol; 1990 Jan 17; 175(3):347-50. PubMed ID: 2157603
    [Abstract] [Full Text] [Related]

  • 10. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.
    Rasmussen K, Stockton ME, Czachura JF.
    Eur J Pharmacol; 1991 Nov 19; 205(1):113-6. PubMed ID: 1811993
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
    Prisco S, Pessia M, Ceci A, Borsini F, Esposito E.
    Eur J Pharmacol; 1992 Apr 07; 214(1):13-9. PubMed ID: 1582449
    [Abstract] [Full Text] [Related]

  • 12. The effect of 5-HT3 receptor antagonists on the morphine-induced excitation of A10 dopamine cells: electrophysiological studies.
    Gifford AN, Wang RY.
    Brain Res; 1994 Feb 28; 638(1-2):325-8. PubMed ID: 8199870
    [Abstract] [Full Text] [Related]

  • 13. 5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat.
    Batsche K, Granoff MI, Wang RY.
    Brain Res; 1992 Oct 02; 592(1-2):273-7. PubMed ID: 1450916
    [Abstract] [Full Text] [Related]

  • 14. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Schechter L, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2003 Dec 01; 50(3):181-90. PubMed ID: 14515335
    [Abstract] [Full Text] [Related]

  • 15. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME.
    Neuroscience; 1988 Feb 01; 24(2):465-76. PubMed ID: 3362349
    [Abstract] [Full Text] [Related]

  • 16. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y, Emori K, Ashby CR.
    Synapse; 1996 Jan 01; 22(1):46-53. PubMed ID: 8822477
    [Abstract] [Full Text] [Related]

  • 17. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.
    Freeman AS, Bunney BS.
    Brain Res; 1987 Mar 03; 405(1):46-55. PubMed ID: 3032350
    [Abstract] [Full Text] [Related]

  • 18. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    Cox RF, Neumeyer JL, Waszczak BL.
    J Pharmacol Exp Ther; 1988 Oct 03; 247(1):355-62. PubMed ID: 3171980
    [Abstract] [Full Text] [Related]

  • 19. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B, Rothwell LA, Seabrook GR.
    Br J Pharmacol; 1994 Jul 03; 112(3):873-80. PubMed ID: 7921615
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT, Christoffersen CL, Serpa KA, Razmpour A.
    Synapse; 1993 Feb 03; 13(2):117-22. PubMed ID: 8446920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.